Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Metoprolol succinate

[1] Metoprolol (Metoprolol Succinate Extended-release)

[1] Metoprolol 💬

[1] ADRB1 💬

[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[4] 57, 58, 113, 193 💬

2

METOPROLOL SUCCINATE (PH. EUR.)

[1] Metoprolol (Metoprolol Succinate Extended-release)

[1] Metoprolol 💬

[1] ADRB1 💬

[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[1] 193 💬

3

Metoprolol succinate + doxazosin

[2] Doxazosin,
Metoprolol (Metoprolol Succinate Extended-release)

[2] Metoprolol ,
Doxazosin 💬

[4] ADRA1A,
ADRA1B,
ADRA1D,
ADRB1 💬

[13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[1] 57 💬